Michael Howell
Chief Tech/Sci/R&D Officer at ZURA BIO LIMITED
Net worth: 642 506 $ as of 2024-05-30
Profile
Michael D.
Howell is the founder of Mountaineer Biosciences, Inc. (founded in 2022) and Galileo Biosystems, Inc. (founded in 2020).
He is currently the Chief Scientific Officer at Zura Bio Ltd.
since 2023.
Previously, he held the position of Senior Director-Translational Medicine at Incyte Corp.
from 2016 to 2020, Associate Director & Principal Scientist at MedImmune LLC from 2013 to 2016, Senior Director-Biomarker & Discovery Research at Immune Tolerance Network in 2012 and 2013, and Chief Scientific Officer at DermTech, Inc. from 2020 to 2022.
He also worked as a Principal Scientist at Boehringer Ingelheim GmbH from 2010 to 2012.
Dr. Howell obtained his undergraduate degree from the University of Messiah and his doctorate from West Virginia University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZURA BIO LIMITED CLASS A
0.19% | 2024-04-21 | 122,382 ( 0.19% ) | 642 506 $ | 2024-05-30 |
Michael Howell active positions
| Companies | Position | Start |
|---|---|---|
| ZURA BIO LIMITED | Chief Tech/Sci/R&D Officer | 2023-04-13 |
Former positions of Michael Howell
| Companies | Position | End |
|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 2022-10-31 |
| INCYTE CORPORATION | Corporate Officer/Principal | 2020-07-31 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2016-10-31 |
Immune Tolerance Network
 Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 2013-11-30 |
Training of Michael Howell
| University of Messiah | Undergraduate Degree |
| West Virginia University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| DERMTECH, INC. | Health Technology |
| INCYTE CORPORATION | Health Technology |
| ZURA BIO LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Immune Tolerance Network
Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Commercial Services |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
- Stock Market
- Insiders
- Michael Howell
